Results 111 to 120 of about 697,452 (285)

Ultra High‐Resolution Ultrasound Features of Carpal Tunnel Syndrome in Transthyretin Amyloidosis: A Cross‐Sectional Study

open access: yesMuscle &Nerve, Volume 73, Issue 5, Page 867-874, May 2026.
ABSTRACT Introduction/Aims Transthyretin amyloidosis (ATTR), including hereditary (hATTR) and wild‐type (wtATTR), often presents initially as carpal tunnel syndrome (CTS), often preceding systemic symptoms by several years. Ultra high‐resolution ultrasound (UHRUS) offers detailed visualization of peripheral nerve morphology, but its application in ATTR‐
Rachana K. Gandhi Mehta   +4 more
wiley   +1 more source

Gender based differences in diabetic peripheral neuropathy [PDF]

open access: yes, 2014
Diabetic peripheral neuropathy (DPN) is one of the common complications of diabetes mellitus. Aim: To find out gender based differences in frequency of DM, age at diagnosis of DM and subsequent onset of DPN, duration of DM and DPN and ...
Furqan, Ahmad   +3 more
core   +1 more source

Mesenchymal Stem Cell Therapy in Type 1 Diabetes Mellitus and Its Main Complications: From Experimental Findings to Clinical Practice [PDF]

open access: yes, 2014
Type 1 diabetes mellitus (T1DM) is a complex multifactorial disorder which involves a loss of self-tolerance leading to the autoimmune destruction of pancreatic β−cells.
Arango Rodriguez, Martha   +3 more
core   +1 more source

Microangiopathy in diabetic polyneuropathy revisited.

open access: yesEuropean review for medical and pharmacological sciences, 2018
Microangiopathy is a major cause in diabetic polyneuropathy (DPN). This review examines evidence from both human and animal studies to elucidate the important microvascular factors in DPN.This is a literature review of articles published on PubMed in English.There is an abundance of evidence linking endoneurial microvascular abnormalities to peripheral
Fang, F.   +3 more
openaire   +2 more sources

The Role of Oxidative Stress, Mitochondrial Function, and Autophagy in Diabetic Polyneuropathy

open access: yesJournal of Diabetes Research, 2017
Diabetic polyneuropathy (DPN) is the most frequent and prevalent chronic complication of diabetes mellitus (DM). The state of persistent hyperglycemia leads to an increase in the production of cytosolic and mitochondrial reactive oxygen species (ROS) and
Sonia Sifuentes-Franco   +3 more
semanticscholar   +1 more source

Acute tetraparesis in a labrador retriever with suspected ectopic insulinoma and paraneoplastic polyneuropathy

open access: yesVeterinary Record Case Reports, Volume 14, Issue 2, May 2026.
Summary This case report describes a 10‐year‐old, male, neutered labrador retriever that was presented with acute non‐ambulatory tetraparesis, later diagnosed with an ectopic insulinoma and paraneoplastic polyneuropathy. Clinical evaluation revealed severe hypoglycaemia, generalised neuromuscular signs and electromyography findings were consistent with
Laryssa Straub   +3 more
wiley   +1 more source

Oral plaque from Type 2 diabetic patients reduces the clonogenic capacity of dental pulp-derived mesenchymal stem cells [PDF]

open access: yes, 2019
Type 2 diabetes (T2D) is a major metabolic disease and a key epigenetic risk factor for the development of additional clinical complications. Among them, periodontitis (PD), a severe inflammatory disease ascribable to a dysregulated physiology and ...
Bordin, Antonella   +9 more
core   +1 more source

MRI of Skeletal Muscles in Participants with Type 2 Diabetes with or without Diabetic Polyneuropathy.

open access: yesRadiology, 2020
BackgroundDiabetic polyneuropathy (DPN) is associated with loss of muscle strength. MRI including diffusion-tensor imaging (DTI) may enable detection of muscle abnormalities related to type 2 diabetes mellitus (DM2) and DPN.PurposeTo assess skeletal ...
Anders Stouge   +7 more
semanticscholar   +1 more source

Loncastuximab Tesirine in a Frail, Heavily Pretreated Patient With Relapsed/Refractory Diffuse Large B‐Cell Lymphoma: A Case Report

open access: yesClinical Case Reports, Volume 14, Issue 4, April 2026.
ABSTRACT Loncastuximab tesirine may offer a feasible, well‐tolerated option for frail, heavily pretreated patients with relapsed/refractory DLBCL and poor performance status when intensive therapies are unsuitable, achieving durable remission with manageable fluid retention through careful monitoring, spironolactone‐based treatment, and dose ...
Reyad Dada, Refaei Belal Ibrahim
wiley   +1 more source

Home - About - Disclaimer - Privacy